blue cross blue shield glp 1 for weight loss IBX members face GLP-1 drug costs after insurance change GLP-1 Drugs: What Employers Need
Description
Retatrutide has been studied in a phase 2 trial involving adults without diabetes but with obesity or preobesity (overweight)

It appears to be a news article or policy commentary piece about Medicare coverage decisions regarding GLP-1 medications rather than a peer-reviewed clinical study

Obesity affects millions of people and is linked to over 200 diseases and cardiovascular problems
C., Lawler, A
